Stock NYKD NYKODE THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Nykode Therapeutics

Equities

NYKD

NO0010714785

Real-time Oslo Bors
Other stock markets
 07:49:31 2024-05-30 am EDT 		5-day change 1st Jan Change
14.61 NOK +0.34% Intraday chart for Nykode Therapeutics -1.62% -31.73%
May. 14 Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024
May. 14 Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Nykode Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

01035.5HSM2oTtLDLJgZWNd9PNwdtoAmkSY73-CqiFJGp-Elc.nTbF7fW-RATkzKb1J5Wd7LAsVz5iAfaIfp_ISB9TRiPVRsa25olNeOTe4g~fb3d463d9365436bacd0d63cf05f4b32

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
14.56 NOK
Average target price
43 NOK
Spread / Average Target
+195.33%
High Price Target
70 NOK
Spread / Highest target
+380.77%
Low Price Target
28 NOK
Spread / Lowest Target
+92.31%

Consensus detail

Consensus revision (last 18 months)

Ratings for Nykode Therapeutics

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NYKD Stock
  4. Consensus Nykode Therapeutics